Staar Surgical Co revenue
Staar Surgical Co's revenue was $239m in fiscal 2025, down 23.7% on the year before. Since fiscal 2009 ($51.1m) it has grown at a compound 10.1% a year. Over the last twelve months it was $340m.
Revenue history
| Fiscal year | 2009Jan 2010 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Jan 2014 | 2014Jan 2015 | 2015Jan 2016 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Jan 2020 | 2020Jan 2021 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Jan 2026 | LTMJul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 51 | 55 | 63 | 64 | 72 | 75 | 77 | 82 | 91 | 124 | 150 | 163 | 230 | 239 | 322 | 314 | 239 | 340 |
| Growth on the year before | — | +7.6% | +14.2% | +1.6% | +13.2% | +3.8% | +2.8% | +6.9% | +9.9% | +36.8% | +21.2% | +8.8% | +41.0% | +3.9% | +34.7% | −2.6% | −23.7% | — |
| Gross profit | 31 | 35 | 42 | 44 | 50 | 49 | 53 | 58 | 64 | 92 | 112 | 118 | 179 | 223 | 253 | 240 | 182 | 260 |
| Gross margin | 61.3% | 63.8% | 67.5% | 69.4% | 69.7% | 65.1% | 68.4% | 70.8% | 70.9% | 73.8% | 74.5% | 72.4% | 77.5% | 93.3% | 78.4% | 76.3% | 76.2% | 76.6% |
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Staar Surgical Co | $340m | 51.3% | 9.2% |
| Procept Biorobotics Corp | $337m | 22.7% | 49.2% |
| Inogen Inc | $354m | 3.2% | 0.5% |
| Angiodynamics Inc | $325m | 8.2% | -1.1% |
| Tactile Systems Technology Inc | $356m | 14.4% | 9.6% |
| Inmode Ltd. | $370m | -6.2% | — |
Compare with peers
- Procept Biorobotics Corp revenue
- Inogen Inc revenue
- Angiodynamics Inc revenue
- Tactile Systems Technology Inc revenue
- Inmode Ltd. revenue
Head to head: PRCT vs STAAINGN vs STAAANGO vs STAASTAA vs TCMD
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies